Concepedia

David Woods

DW

Statistics

Publications

27

Citations

2.4K

H-Index

21

Active since

2008

Affiliations

NYU Langone Health(Current)

Moffitt Cancer Center

University of Colorado Denver

Dana-Farber Cancer Institute

Johns Hopkins University

David Woods is an author at NYU Langone Health specializing in immunology, life sciences, and cancer immunotherapy.

ORCID

Publications per year

2008–2023

27

Publications

27

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

David Woods, Andressa L. Sodré, Alejandro Villagra et al. · Cancer Immunology Research · 2015 · 434 citations · Full text

, , +17

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

Andressa S. Laino, David Woods, Melinda Vassallo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 248 citations · Full text

, , +17

Predictors of responses to immune checkpoint blockade in advanced melanoma

Nicolas Jacquelot, María P. Roberti, David Enot et al. · Nature Communications · 2017 · 201 citations · Full text

, , +17

The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy

David M. Briere, Niranjan Sudhakar, David Woods et al. · Cancer Immunology Immunotherapy · 2017 · 145 citations · Full text

, , +13

Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells

Fengdong Cheng, Maritza Lienlaf, Patricio Perez-Villarroel et al. · Molecular Immunology · 2014 · 139 citations

, , +16

1–5 of 27